Jared Weiss (@drjaredweiss) 's Twitter Profile
Jared Weiss

@drjaredweiss

ID: 377453982

calendar_today21-09-2011 16:11:02

45 Tweet

155 Followers

53 Following

Chul Kim (@chulkimmd) 's Twitter Profile Photo

Truly remarkable 5-year overall survival in ALK+ NSCLC. A great example showing that having right drug(s) for right target can change the course of disease #ASCO20

Jared Weiss (@drjaredweiss) 's Twitter Profile Photo

Was the unblinding of ADAURA an ethical imperative, or a mistake (whether by DSMB or by predefined statistical plan)? Given MOA, should trial have been continued blind to survival maturity?

Jared Weiss (@drjaredweiss) 's Twitter Profile Photo

Anyone have any tips how to actually get on to WCLC oral sessions? I click on day 2 and only get a blank box. Had hoped to watch ADC session going on now.

Jared Weiss (@drjaredweiss) 's Twitter Profile Photo

Excited about the approval of trilaciclib and to share pooled efficacy and quality of life data from the 3 SCLC studies: doi.org/10.1016/j.cllc…. #QoL #SCLC #myelosupression

Jared Weiss (@drjaredweiss) 's Twitter Profile Photo

Looking forward to chairing the OncLive.com Lung Cancer IPC on June 30th at 630pm ET. Join me and expert faculty for updates on lung cancer and a Live Q&A. UNC Lineberger OncLive SOSS #oncliveIPC donnashort Register: bit.ly/3aKdP0U

Looking forward to chairing the <a href="/OncLive/">OncLive.com</a> Lung Cancer IPC on June 30th at 630pm ET. Join me and expert faculty for updates on lung cancer and a Live Q&amp;A. <a href="/UNC_Lineberger/">UNC Lineberger</a> <a href="/OncLiveSOSS/">OncLive SOSS</a> #oncliveIPC <a href="/donnashort/">donnashort</a> Register: bit.ly/3aKdP0U
OncLive SOSS (@onclivesoss) 's Twitter Profile Photo

.Joshua Bauml, MD, of Penn Medicine, discusses the use of osimertinib in EGFR-mutant NSCLC, the utility of the agent as adjuvant therapy, and emerging targeted agents for patients with EGFR exon 20 insertions #lcsm ow.ly/RtcI50EOgcW

Jared Weiss (@drjaredweiss) 's Twitter Profile Photo

Register now for Institutional Perspectives in Lung Cancer: Topics include: • Frontline SCLC • Targeting EGFR in Lung Cancer • Biomarkers and Targeted Therapies in NSCLC • Emerging Options in SCLC—Lurbinectidin, Trilaciclib and Beyond

Register now for Institutional Perspectives in Lung Cancer: Topics include:
• Frontline SCLC
• Targeting EGFR in Lung Cancer
• Biomarkers and Targeted Therapies in NSCLC
• Emerging Options in SCLC—Lurbinectidin, Trilaciclib and Beyond
Jared Weiss (@drjaredweiss) 's Twitter Profile Photo

Excited to participate in Cure's Educated Patient Webinar on Individualized Treatment for Small Cell Lung Cancer on 8/26. Register @ event.on24.com/eventRegistrat…

Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

Great panel to close out #LCLive21 with Drs. Jared Weiss @NarjustDumaMD H. Jack West, MD, FASCO Justin Gainor with some great advice. How do we know if our patients are vulnerable, are safe, are hungry? Ask them. And know the resources your cancer center has available for patients. #LCSM

Great panel to close out #LCLive21 with Drs. <a href="/DrJaredWeiss/">Jared Weiss</a> @NarjustDumaMD <a href="/JackWestMD/">H. Jack West, MD, FASCO</a> <a href="/JustinGainor/">Justin Gainor</a> with some great advice. How do we know if our patients are vulnerable, are safe, are hungry? Ask them. And know the resources your cancer center has available for patients. #LCSM
Jared Weiss (@drjaredweiss) 's Twitter Profile Photo

The #VALIDAct is bad news for clinical #labs and will disrupt #patient care while we are still reeling from the #pandemic. Senator Patty Murray and Richard Burr, please hear our concerns.

Jared Weiss (@drjaredweiss) 's Twitter Profile Photo

Trying to buy iphone through vz plan @ apple store, but carrier keeps rejecting. Apple Support says it's a VZ problem and Verizon Support says it's an apple problem. Anyone see and/or solve this? I'm 4 calls to apple, 3 calls to vz, and 1 trip to apple store in & frustrated.

IASLC (@iaslc) 's Twitter Profile Photo

In this virtual tumor board episode of #LungCancerConsidered, host Stephen V Liu, MD leads a discussion on the management of a patient with Metastatic Squamous NSCLC. Listen to the episode to learn how Pilar Garrido & Jared Weiss would approach this case. Listen now ➡️

In this virtual tumor board episode of #LungCancerConsidered, host <a href="/StephenVLiu/">Stephen V Liu, MD</a> leads a discussion on the management of a patient with Metastatic Squamous NSCLC. Listen to the episode to learn how <a href="/Piuchagarrido/">Pilar Garrido</a> &amp; <a href="/DrJaredWeiss/">Jared Weiss</a> would approach this case. Listen now ➡️